Study Closure Process Entropy is not a method Rachel Sheppard Regulatory Director, OCRSS.

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

MONITORING OF SUBGRANTEES
CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
Contract CloseOut.
USC Clinical Trials Office (CTO) Answers to CTOs who, what, when, and how questions Soheil Jadali Director, Clinical Trial Office.
USC Clinical Trials Office (CTO) Submitting your Studies to CTO For Processing Soheil Jadali Director, Clinical Trial Office.
HELP! The FDA is Coming! Margaret M. Groves, JD, CRA Director, Clinical Trials Quality Assurance (CTQA) School of Medicine (SOM) Compliance Office.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
Clinical Trials Workshop
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
“So You Think You Know GCP …” Session S794 Jill Matzat, RN, BSN, CCRA, CCRT President, Medical Research Management & CRA Solutions, Inc. Paul Below, CCRA,
PREPARING FOR SUPPLEMENTAL MONITORING PERKINS COMPLIANCE Monieca West ADHE Federal Program Manager October 19, 2012.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
6/1/09.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
Monitoring, Audits, and Inspection Oh my! Rachel Sheppard Regulatory Director, OCRSS.
Invoicing, Cash Receipts and Revenue Recognition
STUDY CLOSE OUT KEMRI-Wellcome Trust Research Programme Version: 4-Nov-2008.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Budget Development Presented by: Jean Mercer Associate Director for Clinical Research Administration Office of Clinical Research – School of Medicine.
Regulatory and Hospital Approval Are we there yet? Rachel Sheppard Regulatory Director, OCRSS.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Finance and Contract Pre-Award Process Rachel Sheppard Regulatory Director, OCRSS.
Essential Documents and Regulatory Files Lack of planning can constitute an emergency Rachel Sheppard Regulatory Director, OCRSS.
Arthi Ramakrishnan SHINE Site Manager Stroke Hyperglycemia Insulin Network Effort (SHINE) Stroke Hyperglycemia Insulin Network Effort (SHINE) Regulatory.
LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.
Leslie Howes, MPH, CIP Alyssa Speier, MS, CIP September 24, 2014 Investigator Manual: ra/investigator-manual/
Financial Management of Sponsored Awards: Confessions From A Department Administrator.
How Grant/Research Administrators and OSR Can Work Together Better.
JCRI Business Operations – Post-Award. Processes relating to the collection of sponsored clinical trial funding.
Business Operations Pre-Award. What is required to begin the business process? Possible indicators CDA executed Cancer Center MDG/PRC approvals Department.
Federal Program Monitoring Overview and Organization.
Getting a study done at Jefferson:. Startup Activities: Image courtesy of CITI Program Clinical Research Coordinator course.
Stanley Estime, MSCI October 19, 2015 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Investigational Devices and Humanitarian Use Devices June 2007.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
CLINICAL RESEARCH STUDIES Business & Finance (B &F) Prospective Patricia W. Davis Director of Research Office of Business & Finance
IP Accountability in Outpatient Clinical Trials
Sponsor Visits and Monitoring
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Business Operations Pre-Award. Confidential Disclosure Agreements (CDA)/ Non-Disclosure Agreements (NDA)
Good Clinical Practices and Best Research Practices at MU Health Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
IP Accountability in Outpatient Clinical Trials Jessica Rinaldi, CCRP Farber Institute for Neurosciences.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Remote Site Initiation Visits
PRCSG Training Webinar: Budget for Industry Sponsored Studies
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
The Role and Responsibilities of the Clinical Research Coordinator
Preparing for and Handling Monitoring Visits and Audits
Responsibilities of Sponsor, Investigator and Monitor
Award Closeout Checklist Discussion
Investigator of Record – Definition
LNH Pharma A Trusted Partner.
Worldwide Development Quality Assurance
Study Close-Out Procedures
Regulatory Binder: Maintaining Essential Study Documentation
Elements of an Organized Regulatory Binder
Investigator of Record – Definition
Investigator of Record – Definition
Presentation transcript:

Study Closure Process Entropy is not a method Rachel Sheppard Regulatory Director, OCRSS

Timing Sponsor/Investigator notification of closure and data lock No identifiable data collection after closure Case by case review when to close with IRB

Clinical Preparation Usually receive notification of closure Scheduling visit and coordinating departments Resolve outstanding queries Have all subject source documents available Complete IP accountability records/inventory Prepare equipment for return Communicate with study team (Investigators, regulatory, financial, hospital personnel)

Regulatory Preparation Notify IRB and Hospital offices of closure Resolve any outstanding monitoring findings Check all licenses and CVs Review Financial Disclosures Review/Provide Delegation of Authority Log Secure any sequestered data and place with files for storage

Financial Preparation Verify the status of A/R and payments Notify hospital billing and contracting Reconcile account Review payment terms in CTA Calculate final payment due Review with PI

Sponsor Activities Return/destruction of IP or instruction to staff Review of Investigator obligations Storage plan Regulatory review CRF review AE/Deviation review Closure of all open items Communication of FDA status (if applicable) Letter/ issued to site for closure

Best practice Pre closure checklist Accessibility of files Know storage requirements Request electronic CRF on CD for storage FD after one year if change Who keeps records Base transfer to long term storage on audit risk